Health and economic benefits of advanced pneumatic compression devices in patients with phlebolymphedema.

Affiliation

Division of Cardiovascular Medicine, Stanford University School of Medicine, Falk Cardiovascular Research Center, Stanford, Calif. Electronic address: [Email]

Abstract

Phlebolymphedema (chronic venous insufficiency-related lymphedema) is a common and costly condition. Nevertheless, there is a dearth of evidence comparing phlebolymphedema therapeutic interventions. This study sought to examine the medical resource utilization and phlebolymphedema-related cost associated with Flexitouch (FLX; Tactile Medical, Minneapolis, Minn) advanced pneumatic compression devices (APCDs) relative to conservative therapy (CONS) alone, simple pneumatic compression devices (SPCDs), and other APCDs in a representative U.S. population of phlebolymphedema patients.

Keywords

Cellulitis,Flexitouch,Medical resource utilization,Phlebolymphedema,Pneumatic compression device,Venous ulcer,

OUR Recent Articles